Health

From $28,000 to $40: The HIV injection that will reach poor countries first

The FDA approved a generic version of lenacapavir, the only injection in the world for HIV prevention that is administered only twice a year, and its path to 120 low- and middle-income countries has been shortened. The first shipments are expected by the end of the year, but to provide it to the 20 million people worldwide who need preventive treatment, funding is still lacking.